What Is SM1?
A long-acting incretin receptor agonist studied for incretin signaling and glucose-metabolism research.
01Definition
SM1 is a metabolic research compound. A long-acting incretin receptor agonist studied for incretin signaling and glucose-metabolism research. It is also known as incretin receptor agonist.
Sequence · Synthetic incretin analog
02Research Mechanism
SM1 is a long-acting synthetic analog of incretin, acting as an agonist of the incretin receptor. Research models study its role in incretin signaling, glucose-dependent insulin secretion, and energy-homeostasis pathways.
Research framing only · No human-use claims
03Key Facts
| Classification | Metabolic |
| Molecular weight | 4,113.58 g/mol |
| Also known as | incretin receptor agonist |
| Purity spec | ≥99% HPLC |
| Verification | MZ Biolabs · 5-panel |
| Use | Research Use Only |
04FAQ
What is SM1?
SM1 is a metabolic research compound. A long-acting incretin receptor agonist studied for incretin signaling and glucose-metabolism research. It is also known as incretin receptor agonist. It is supplied strictly for laboratory research use.
What class of compound is SM1?
SM1 is categorized as Metabolic and is studied alongside related compounds in that research area.
What is the molecular weight of SM1?
SM1 has a molecular weight of 4,113.58 g/mol.
How is SM1 tested?
Every Ethos Bio lot of SM1 is analyzed by an independent third-party laboratory (MZ Biolabs, Arizona) on a five-point panel — HPLC purity, mass-spec identity, endotoxin, heavy metals, and sterility — with a batch-specific Certificate of Analysis.